Niemann-Pick Disease, Type A
Showing 9976 - 10000 of >10,000
Nasal IL 1 Beta ,IL 3 Level and Their Effects in COPD Patients
Not yet recruiting
- Copd Patients
- IL B,IL 3 in nasal swap and serum
- (no location specified)
Aug 4, 2023
COVID-19, Hospitalized COVID-19 Patients Trial in Zgharta, Tripoli (Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab)
Recruiting
- COVID-19
- Hospitalized COVID-19 Patients
- Lopinavir / Ritonavir
- +3 more
-
Zgharta, North, Lebanon
- +1 more
Jun 28, 2023
Research Repository on Neurodegenerative Disease
Recruiting
- Frontotemporal Degeneration(FTD)
- +8 more
- No intervention
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 9, 2022
Pancreatic Ductal Adenocarcinoma Trial in Spain (Gemcitabine, Nab paclitaxel, NLM-001)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Gemcitabine
- +3 more
-
Santiago De Compostela, A Coruña, Spain
- +5 more
Dec 5, 2022
Dermatomyositis, Adult Type Trial in Xi'an (JAK Inhibitor)
Recruiting
- Dermatomyositis, Adult Type
- JAK Inhibitor
-
Xi'an, Shaanxi, ChinaDepartment of Rheumatology, the First Affiliated Hospital of Xi'
Jul 15, 2021
BIOLUX P-III All-Comers Passeo-18 Lux Registry
Completed
- Atherosclerosis
- Peripheral Artery Disease
- Passeo-18 Lux
-
Cairns, Australia
- +44 more
Aug 12, 2022
Hyperphosphatemia Trial in China (VS-505, Sevelamer Carbonate)
Completed
- Hyperphosphatemia
- VS-505
- Sevelamer Carbonate
-
Beijing, Beijing, China
- +22 more
Oct 17, 2022
Congenital Heart Disease, Bradycardia Sinus Trial in Los Angeles (Closed loop stimulation)
Terminated
- Congenital Heart Disease
- Bradycardia Sinus
- Closed loop stimulation
- Standard rate response
-
Los Angeles, CaliforniaUniversity of California at Los Angeles
Dec 22, 2022
Obesity, Metabolic Disease Trial in Riyadh (Kale supplement, Peas supplement)
Recruiting
- Obesity
- Metabolic Disease
- Kale supplement
- Peas supplement
-
Riyadh, Saudi ArabiaCommunity Health Department, Applied Medical Sciences, King Saud
Jan 13, 2022
Multiple Myeloma Trial (Continued treatment adapted to the response)
Completed
- Multiple Myeloma
- Continued treatment adapted to the response
- (no location specified)
Jan 14, 2023
Testing for Chronic Graft Versus Host Disease, CATCH Study
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Biospecimen Collection
- +6 more
-
Gainesville, Florida
- +6 more
Jan 25, 2023
Alzheimer, Mild Cognitive Impairment Trial in Boca Raton, New York, Madison (Placebo, Eligard 22.5Mg Suspension for Injection)
Recruiting
- Alzheimer Disease
- Mild Cognitive Impairment
- Placebo
- Eligard 22.5Mg Suspension for Injection
-
Boca Raton, Florida
- +2 more
Jan 24, 2023
Diabetic Nephropathy Trial in Nice (telmisartan during 6 months, Losartan during 6 months, blood sample)
Completed
- Diabetic Nephropathy
- telmisartan during 6 months
- +2 more
-
Nice, FranceCHU de Nice
May 13, 2022
Tissue Perfusion in Peripheral Arterial Disease (EVTI-PAD)
Not yet recruiting
- Peripheral Arterial Disease
- +2 more
- Revascularization
- (no location specified)
Oct 3, 2022
Xerostomia Due to Hyposecretion of Salivary Gland Trial in Cairo (Chamomile, Saline mouthwash)
Completed
- Xerostomia Due to Hyposecretion of Salivary Gland
- Chamomile
- Saline mouthwash
-
Cairo, EgyptAin Shams University
Nov 1, 2023
Anemia, Sickle Cell, Sickle Cell Disease Trial in Pittsburgh, Lagos (Hydroxyurea, Epoetin Alfa)
Not yet recruiting
- Anemia, Sickle Cell
- Sickle Cell Disease
- Hydroxyurea
- Epoetin Alfa
-
Pittsburgh, Pennsylvania
- +1 more
Aug 4, 2022
Liver Transplantation in Incidental
Recruiting
- Adult Combined Hepatocellular-Cholangiocarcinoma
- liver transplantation
-
Istanbul, TurkeyGroup Florence Nightingale Hospitals
Feb 26, 2022
Parkinson Disease Trial (Autonomy supported learning, Practice with predetermined feedback)
Not yet recruiting
- Parkinson Disease
- Autonomy supported learning
- Practice with predetermined feedback
- (no location specified)
Jul 24, 2023
Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)
Active, not recruiting
- Ewing Sarcoma
- +4 more
- Allogeneic HCT
- Donor NK Cell Infusion
-
Milwaukee, Wisconsin
- +1 more
Apr 5, 2022
Neurodegenerative Diseases Trial in Ibiza (High intensity functional training, classic training group)
Recruiting
- Neurodegenerative Diseases
- High intensity functional training
- classic training group
-
Ibiza, Islas Baleares, SpainAsociación de Esclerosis Múltiple de Ibiza y Formentera (AEMIF)
Jul 28, 2022
Type 2 Diabetes Trial in San Mateo (Online Diabetes Self-Management Education and Support (DSMES) Program, Standard of Care)
Recruiting
- Type 2 Diabetes
- Online Diabetes Self-Management Education and Support (DSMES) Program
- Standard of Care
-
San Mateo, CaliforniaEvidation Health
May 31, 2022
Popeye Syndrome Trial in Roeselare (Botulinum toxin type A, Placebo)
Recruiting
- Popeye Syndrome
- Botulinum toxin type A
- Placebo
-
Roeselare, BelgiumAZ Delta
Oct 15, 2021
Chronic Kidney Disease Requiring Chronic Dialysis Trial in Seoul (A medium cut-off dialyzer (Theranova) will be used for HDx., A
Recruiting
- Chronic Kidney Disease Requiring Chronic Dialysis
- A medium cut-off dialyzer (Theranova) will be used for HDx.
- A synthetic high-flux dialyzer (Polyflux)
-
Seoul, Korea, Republic ofGangnam Severance Hospital
Aug 2, 2022
Cardiovascular Disease Risk Reduction Trial in Tallahassee (Health for Hearts United Planning for Health, Health for Hearts
Recruiting
- Cardiovascular Disease Risk Reduction
- Health for Hearts United Planning for Health
- +3 more
-
Tallahassee, FloridaCenter on Better Health and Life for Underserved Populations
Aug 1, 2022